[Spironolactone protection against experimental cardiopathy due to digitoxin, disodium phosphate and oil].
D000818:Animals; D009202:Cardiomyopathies / Q000139:chemically induced* / Q000473:pathology; D004074:Digitoxin / Q000037:antagonists & inhibitors; D004790:Enzyme Induction; D006321:Heart / Q000187:drug effects; D008854:Microscopy, Electron; D009206:Myocardium / Q000473:pathology; D009336:Necrosis / Q000473:pathology; D009821:Oils; D010710:Phosphates; D051381:Rats; D012964:Sodium; D013148:Spironolactone / Q000627:therapeutic use*
D009821:Oils; D010710:Phosphates; D013148:Spironolactone; D012964:Sodium; D004074:Digitoxin
Protection par la spironolactone contre la cardiopathie expérimentale causée par la digitoxine, le phosphate disodique et l'huile.